ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
8 hedge funds and large institutions have $1.03M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
1
Calls
$266K
Puts
$301K
Net Calls
-$35K
Net Calls Change
+$303K
Top Buyers
| 1 |
BP
Ballentine Partners
Waltham,
Massachusetts
|
$104K |
| 2 |
GHAM
Gilman Hill Asset Management
New Canaan,
Connecticut
|
$104K |
| 3 |
UBS Group
Zurich,
Switzerland
|
$41K |
| 4 |
VF
Virtu Financial
New York
|
$659K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$0 |
| 2 |
Jane Street
New York
|
$108K |
| 3 |
Morgan Stanley
New York
|
$7K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $659K | +$12.3K | +590 | +2% |
|
|
2
Jane Street
New York
| $108K | -$260K | -12,538 | -71% |
|
|
BP
3
Ballentine Partners
Waltham,
Massachusetts
| $104K | +$104K | +5,000 | New |
|
|
GHAM
4
Gilman Hill Asset Management
New Canaan,
Connecticut
| $104K | +$104K | +5,000 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $41K | +$38.5K | +1,831 | +1,526% |
|
|
CG
6
Cutler Group
San Francisco,
California
| $8K | – | – | – |
|
|
7
Morgan Stanley
New York
| $7K | -$2.9K | -158 | -29% |
|
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$319K | -11,867 | Closed |
|